SEC Form SC 13G/A filed by AeroClean Technologies Inc. (Amendment)

$AERC
Environmental Services
Utilities
Get the next $AERC alert in real time by email
SC 13G/A 1 tm235829d2_sc13g.htm SC 13G/A

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

SCHEDULE 13G/A

(Amendment No. 1)*

 

Under the Securities Exchange Act of 1934

 

 

Molekule Group, Inc.

(Name of Issuer)

 

Common Stock, par value $0.01 per share

(Title of Class of Securities)

 

007744105

(CUSIP Number)

 

December 31, 2022

(Date of Event which Requires Filing of this Statement)

 

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

 

  ¨ Rule 13d-1(b)
  ¨ Rule 13d-1(c)
  x Rule 13d-1(d)

 

* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
   
  The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 

 

 

 

CUSIP No. 007744105   Page 1 of 4

 

1 NAMES OF REPORTING PERSONS
David Helfet, M.D.
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a)¨ (b)¨ 
3 SEC USE ONLY
 
4 CITIZENSHIP OR PLACE OF ORGANIZATION
United States

 

NUMBER OF SHARES
BENEFICIALLY OWNED BY
EACH REPORTING PERSON
WITH
5 SOLE VOTING POWER
770,107
6 SHARED VOTING POWER
0
7 SOLE DISPOSITIVE POWER
770,107
8 SHARED DISPOSITIVE POWER
0

 

9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
770,107
10 CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) ¨
 
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
2.5%*
12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
IN
       

 

* Based on 30,427,750 shares of common stock, par value $0.01 per share (“Common Stock”), of Molekule Group, Inc. (the “Issuer”) outstanding as of January 12, 2023, as reported on the Issuer’s Current Report on Form 8-K, filed with the Securities and Exchange Commission (the “SEC”) on January 12, 2023.

 

 

 

 

CUSIP No. 007744105   Page 2 of 4

 

Item 1(a) Name of Issuer:
   
  Molekule Group, Inc.

 

Item 1(b) Address of Issuer’s Principal Executive Offices:
   
  10455 Riverside Dr., Palm Beach Gardens, FL 33410

 

Item 2(a) Name of Persons Filing:
   
  David Helfet, M.D.

 

Item 2(b) Address of Principal Business Office or, if none, Residence:
   
  10455 Riverside Dr., Palm Beach Gardens, FL 33410

 

Item 2(c) Citizenship:
   
  United States

 

Item 2(d) Title of Class of Securities:
   
  Common stock, par value $0.01 per share

 

Item 2(e) CUSIP No.:
   
  007744105

 

Item 3 If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
   
  This statement is not filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c).

 

Item 4 Ownership:
   
(a) Amount beneficially owned:
 
770,107

 

(b) Percent of class:
 
2.5%*

 

 

 

 

CUSIP No. 007744105   Page 3 of 4

 

(c) Number of shares as to which the person has:
 
(i) Sole power to vote or to direct the vote:
 
770,107
 
(ii) Shared power to vote or to direct the vote:
 
None
 
(iii) Sole power to dispose or to direct the disposition of:
 
770,107
 
(iv) Shared power to dispose or to direct the disposition of:
 
None

 

* Based on 30,427,750 shares of Common Stock outstanding as of January 12, 2023, as reported on the Issuer’s Current Report on Form 8-K, filed with the SEC on January 12, 2023.

 

Item 5 Ownership of Five Percent or Less of a Class:
   
  If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following x.

 

Item 6 Ownership of More than Five Percent on Behalf of Another Person:
   
  Not applicable.

 

Item 7 Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person:
   
  Not applicable.

 

Item 8 Identification and Classification of Members of the Group:
   
  Not applicable.

 

Item 9 Notice of Dissolution of Group:
   
  Not applicable.

 

Item 10 Certifications:
   
  Not applicable.

 

 

 

 

CUSIP No. 007744105   Page 4 of 4

 

SIGNATURE

 

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

Date: February 8, 2023    
  By: /s/ David Helfet, M.D.
    David Helfet, M.D.

 

 

 

Get the next $AERC alert in real time by email

Chat with this insight

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$AERC

DatePrice TargetRatingAnalyst
6/14/2022Buy → Hold
The Benchmark Company
2/1/2022Speculative Buy
Benchmark
More analyst ratings

$AERC
Press Releases

Fastest customizable press release news feed in the world

See more
  • AeroClean Technologies and Molekule Announce the Close of All-Stock Merger

    Establishes an industry-leading provider of premium, FDA-cleared air purification products and solutionsPositions the combined company to selectively pursue additional value-creating M&A opportunities within the broader indoor air quality ("IAQ") and cleantech industriesPowerful brand value and large installed base of over 350,000 air purification units creates an opportunity to drive recurring revenues through consumables and the launch of a software solution to monitor and control air quality on an enterprise-wide basisRecent developments include the release of Molekule's PECO-HEPA Tri-Power Filter for Air Pro, Air Mini+ and Air Mini; AeroClean's Pūrgo™ air purifier receiving FDA clearance

    $AERC
    Environmental Services
    Utilities
  • AeroClean's Pūrgo™ Air Purifier Receives FDA Clearance for the Elimination of SARS-CoV-2

    Additional Testing Being Performed to Confirm Elimination of Influenza and RSV PALM BEACH GARDENS, Fla., Dec. 07, 2022 (GLOBE NEWSWIRE) -- AeroClean Technologies ("AeroClean" or the "Company") (NASDAQ:AERC), a leading air hygiene technology company, today announced that, the U.S. Food and Drug Administration ("FDA") has granted AeroClean 510k clearance (K223328) to update its Pūrgo™ air purifier's ("Pūrgo™") indications for use to include the elimination of SARS-CoV-2, the RNA virus that causes COVID-19. The FDA has reviewed the laboratory performance data and confirmed the applicability of Pūrgo to remove SARS-CoV-2 from the air in indoor environments. The clearance adds SARS-CoV-2 to th

    $AERC
    Environmental Services
    Utilities
  • AeroClean Reports Third Quarter 2022 Financial Results

    PALM BEACH GARDENS, Fla., Nov. 14, 2022 (GLOBE NEWSWIRE) -- AeroClean Technologies ("AeroClean" or the "Company") (NASDAQ:AERC), a leading air hygiene technology company, today reported financial results for the three and nine months ended September 30, 2022 ("Q3 2022"). Third Quarter 2022 Highlights and Recent Developments The Company entered into a definitive agreement with Molekule, Inc. ("Molekule"), a market leader for premium air purifiers, to combine in an all-stock merger that the Company believes will establish a combined company as a market leader for premium, FDA-cleared air purification products, and solutions.Molekule recently began collaboration with key customers across th

    $AERC
    Environmental Services
    Utilities

$AERC
Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

See more

$AERC
Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

See more

$AERC
SEC Filings

See more

$AERC
Leadership Updates

Live Leadership Updates

See more
  • AeroClean Announces Appointment of Jimmy Thompson as Vice President of Strategic Sales

    Healthcare Technology Expert To Lead Targeted Sales Efforts For FDA-Cleared Germicidal UV-C Air Hygiene Technology PALM BEACH GARDENS, Fla., June 08, 2022 (GLOBE NEWSWIRE) -- AeroClean Technologies ("AeroClean" or the "Company") (NASDAQ:AERC), a leading air hygiene technology company and producer of patented UV-C LED technology inside its innovative Pūrgo™ air purification device, announces Jimmy Thompson has joined the Company as Vice President of Strategic Sales. The addition of Thompson to the AeroClean team is a strategic investment to support core business and revenue growth within targeted industry verticals. Along with driving sales initiatives, Thompson will also be focused on dev

    $AERC
    Environmental Services
    Utilities
  • AeroClean Announces Appointment of Timothy J. Scannell to Board of Directors

    PALM BEACH GARDENS, Fla., May 12, 2022 (GLOBE NEWSWIRE) -- AeroClean Technologies ("AeroClean" or the "Company") (NASDAQ:AERC), a pathogen elimination technology company harnessing patented UV-C LED technology with Pūrgo™ to significantly reduce and remove harmful pathogens to keep work, play and life going, today announced the appointment of Timothy J. Scannell, former President and Chief Operating Officer at Stryker, to its Board of Directors (the "Board"). On May 11, 2022, the Board appointed Mr. Scannell as a new director on the Board, chair of the Nominating and Corporate Governance Committee and a member of the Compensation Committee. Mr. Scannell brings over 30 years of experienc

    $AERC
    $NVCR
    $PODD
    $RNLX
    Environmental Services
    Utilities
    Medical/Dental Instruments
    Health Care

$AERC
Financials

Live finance-specific insights

See more
  • AeroClean Technologies and Molekule to Combine in an All-Stock Merger Establishing an Industry-Leading Provider of Premium, FDA-Cleared Air Purification Products and Solutions

    Transaction Highlights Creates a pro forma company with a substantial base of revenues, a solid balance sheet and a path to profitability.A broad range of highly complementary, proprietary and patented, FDA-cleared air purification devices.Powerful brand value and recognition with an installed base of over 350,000 air purification units, providing a foundation for growing recurring revenues from both consumables and the launch of a SaaS software solution to enable facility managers to monitor and control individual room air quality on an enterprise wide basis.Expected double-digit organic revenue growth for the combined company, with gross profit expected to grow faster than revenues due to

    $AERC
    Environmental Services
    Utilities

$AERC
Large Ownership Changes

This live feed shows all institutional transactions in real time.

See more